Search - tctmd.com

Displaying 61 - 80 of 325

Sort: Relevancy | Date

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

October 25, 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients

Presentation TCT 2023

TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients

Presenter: Sophie Offen

October 25, 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presentation TCT 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presenter: Ji-Yeon Kim

October 25, 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presentation TCT 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presenter: Myeong-Ki Hong

October 25, 2023

TCT 7: Strategy of Dual Antiplatelet Therapy for Patients With ST elevation myocardial infarction or Non-ST elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

Presentation TCT 2023

TCT 7: Strategy of Dual Antiplatelet Therapy for Patients With ST elevation myocardial infarction or Non-ST elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

Presenter: Toshiki Kuno

October 24, 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

October 24, 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients AfterTAVI

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

Guided Antiplatelet Therapy: Why, and in Whom?

Presentation TCT 2023

Guided Antiplatelet Therapy: Why, and in Whom?

Presenter: Jurrien Ten Berg

October 24, 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presentation TCT 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presenter: Hyo-Soo Kim

October 24, 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presentation TCT 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presenter: Harold Dauerman

October 24, 2023

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

September 21, 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

TCT 151: Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Presentation TCT 2022

TCT 151: Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Presenter: Sungsoo Cho

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

September 18, 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Presenter: Anders Kramer

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.